Company news

United Therapeutics Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum

September 15, 2025

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress

September 11, 2025

United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis

September 1, 2025

United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

August 28, 2025

3D Systems Reports Second Quarter 2025 Financial Results

August 11, 2025

United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program

July 31, 2025

United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results

July 29, 2025

United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025

July 15, 2025

United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver

June 23, 2025

United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension

June 22, 2025

United Therapeutics Corporation Reports First Quarter 2025 Financial Results

April 29, 2025

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference

April 20, 2025

United Therapeutics Corporation to Report First Quarter 2025 Financial Results Before Market Open on Wednesday, April 30, 2025

April 15, 2025

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific Sessions

April 3, 2025

United Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to Work

April 1, 2025

United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025

March 3, 2025

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

February 25, 2025

United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference

February 23, 2025

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025

February 18, 2025

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

February 3, 2025

United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

February 2, 2025

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress

January 20, 2025

United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 5, 2025

United Therapeutics Announces Successful World’s First UKidney Transplant

December 16, 2024

United Therapeutics Corporation to Present at the UBS Global Healthcare Conference

November 4, 2024

United Therapeutics Corporation Reports Third Quarter 2024 Financial Results

October 29, 2024

United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024

October 22, 2024

United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service

October 22, 2024

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting

September 23, 2024

United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever

September 9, 2024

United Therapeutics Corporation Reports Second Quarter 2024 Financial Results

July 30, 2024

United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024

July 23, 2024

United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

July 9, 2024

United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors

June 26, 2024

United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

June 4, 2024

United Therapeutics Corporation Reports First Quarter 2024 Financial Results

April 30, 2024

United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024

April 23, 2024

CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant

April 23, 2024

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference

April 15, 2024

United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation

March 25, 2024

United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024

March 4, 2024

United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference

February 26, 2024

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results

February 20, 2024

United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process

February 20, 2024

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024

February 13, 2024

United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 28, 2023

United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger

December 12, 2023

United Therapeutics and Miromatrix Medical Announce Successful Tender Offer

December 11, 2023

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024

December 6, 2023

United Therapeutics Corporation Reports Third Quarter 2023 Financial Results

October 31, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 22 decks. Every deck is listed under its year.